Please attend Enamine/Bienta G5 booth at the ELRIG Drug Discovery 2017 Meeting! At the photo: Iaroslava Kos, Ph.D., Bienta Business Development Manager, is presenting our poster […] Read More
Author: Anna Pashkova
Researchers from Bienta/Enamine presented a poster during MIPTEC exhibition’2017 in Basel, Switzerland: “Reduced cardiotoxicity of spiro-tetrahydropyran bupivacaine analogues”. The goal of this study was to create active structural […] Read More
Sergey Zozulya, V.P. Biology at Enamine, will be a speaker at the 4th year of the Summer Prague School ADVANCES IN DRUG DISCOVERY. Drug Discovery […] Read More
The new Integrative Biology and Medicine Conference will be held in Kyiv, October 2-7, 2017. Main topics of the conference are bioinformatics, systems biology, evolution and […] Read More
To address rapidly growing demand in in vivo pharmacokinetic and toxicology studies, Bienta is currently building a new animal research facility. The new in vivo […] Read More
Location: Kyiv, Ukraine We are seeking a talented self-motivated junior scientist to join our growing in vivo team. The successful candidate will be involved in […] Read More
Enamine and the European Molecular Biology Laboratory (EMBL) agreed to a collaboration through which Enamine will provide library synthesis, medicinal chemistry, and biological services for […] Read More
A brief video tour around the BIENTA laboratories in Kiev is available now. Welcome!
Background: Predicting cardiac toxicity is one of the most important challenges in drug discovery. Over the past 25 years, several non-cardiac drugs got under investigation […] Read More
Sergey Zozulya, Bienta’s CTO, participated in 3rd Prague Summer School Advances in Drug Discovery, with the lecture “High-throughput screening of compound libraries”. The School took […] Read More